Alembic Pharmaceuticals Reports Sustainability Progress, Highlights ESG Goals and Operational Performance in FY2025-26

Alembic Pharmaceuticals Reports Sustainability Progress, Highlights ESG Goals and Operational Performance in FY2025-26​

Alembic Pharmaceuticals Limited (APL) has published its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026. The report details the company's operational footprint, commitment to environmental stewardship, social responsibility, and governance frameworks across various aspects of its business activities.

The BRSR outlines APL’s sustained efforts toward integrating Environmental, Social, and Governance (ESG) principles into its core strategy, while setting ambitious targets for decarbonization and resource efficiency.

Business Overview and Operations​

APL is a major player in the pharmaceutical sector, specializing in the manufacture and trade of active pharmaceutical intermediates and finished dosage formulations, contributing 100% of its turnover from this primary activity. The company’s operations span both domestic and international markets, serving across 74 countries internationally. Exports contribute 57% to the total turnover.

The company maintains a presence through 12 plants nationally and three offices internationally. Financial metrics from the reporting period include paid-up capital of 39.31 Crore.

Key organizational statistics for the financial year are presented below:

Environmental Stewardship and Green Initiatives​

APL has placed a significant focus on environmental risk mitigation and resource efficiency. The company established ambitious targets aimed at achieving environmental sustainability in line with its operational scale.

Climate Change and Energy Targets:
The company aims for a near-term reduction of 63% in absolute scope 1, 2, and 3 GHG emissions by FY2034 from a FY2022 baseline. The long-term target is a 90% reduction of the same emissions by FY2050.

In terms of energy transition, APL has invested in renewable sources, including establishing a dedicated 24 MW solar park at Bhatpur, Vadodara, and implementing windmill installations in Kutch. This commitment resulted in the company's renewable energy share reaching 58.8% of its overall energy mix.

GHG Emissions Performance:
Regarding GHG emissions for the financial year, the total Scope 1 emissions stood at 91,510 tCO2e, and Total Scope 2 emissions were recorded at 54,402 tCO2e. The company achieved a 12.60% reduction in its Scope-1 + 2 emissions compared to the base year of FY2020-21 and recorded an 8.45% reduction from the previous fiscal year (FY2024-25).

Water and Waste Management:
The company is committed to Zero Liquid Discharge (ZLD) at all API sites, ensuring that wastewater is treated and repurposed for utilities and gardening in formulation plants.

In waste management, APL maintains a robust standard operating procedure for hazardous waste. High-calorific value waste is directed for co-processing with the cement industry, while boiler ash is sent to brick manufacturing units. The company reported generating 45,835 metric tons of total waste and implemented measures such as recycling 5,122 MT of non-hazardous waste.

Social Governance and Human Rights Commitment​

The report highlights a strong commitment to employee well-being, diversity, and human rights within the organization and its supply chain partners.

Human Capital Development:
APL reported that the assessment of both employees and workers conducted focused on their well-being and safety standards. A significant achievement noted was the 100% rate of career review for all permanent employees and staff during the financial year, with the same commitment extended to their respective workforce.

Ethical Procurement and Supply Chain:
The company maintains a comprehensive Sustainable Procurement Policy, requiring suppliers to submit a signed code of conduct and undergo systematic checks through a dedicated checklist format. This ensures that inputs are sourced responsibly. A critical percentage was recorded in the sourcing from Micro Small and Medium Enterprises (MSMEs) or small producers, which stood at 22% for FY2025-26, up from 18% in the previous financial year.

Leadership Oversight:
The strategic oversight of sustainability matters is managed by the company’s Risk Management Committee, with both Managing Directors, Mr. Pranav Chirayu Amin and Mr. Shaunak Chirayu Amin, providing direct guidance to ensure alignment with corporate objectives.

Reporting Assurance​

The BRSR Core indicators were independently assessed via a Reasonable Assurance engagement conducted by Bureau Veritas (India) Private Ltd. The assurance opinion confirmed that the disclosed information was prepared in all material respects according to SEBI requirements.

APLLTD Stock Price Movement​

Today, Alembic Pharmaceuticals Limited shares edged higher in post-market trading, settling at ₹837.40 and marking a 2.58% gain on the stock. Traders clocked strong activity as nearly 109,731 shares were transacted in the session.